Status:
COMPLETED
Respiratory Outcome at Adolescence of Very Low Birthweight Infants
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Premature Baby 26 to 32 Weeks
Bronchopulmonary Dysplasia
Eligibility:
All Genders
14-15 years
Phase:
NA
Brief Summary
EPIPAGEADO is an observational study. Respiratory symptoms and lung function will be evaluated in very low birth weight and term infants, born in 1997 and included in the French EPIPAGE cohort.
Detailed Description
EPIPAGEADO is a multicenter observational study:- to evaluate respiratory symptoms and lung function at adolescence in very low birthweight (VLBW) children, to identify perinatal risk factors for pers...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Children born in 1997, and included at birth in the French EPIPAGE cohort
- Absence of severe neurologic impairment, with impossibility of reliable lung function tests
- Acceptance of the child and his/her parents
- Exclusion criteria :
- Severe neurologic impairment, with impossibility of reliable lung function tests
- Absence of child's or parents' acceptance
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
355 Patients enrolled
Trial Details
Trial ID
NCT01424553
Start Date
October 1 2011
End Date
April 1 2015
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Necker
Paris, France, 75015